CTLA4 and non-small cell lung carcinoma: The clonal neoantigen load was correlated with OS in lung adenocarcinoma (LUAD), and the sensitivity to PD-1 and CTLA-4 blockade in patients with NSCLC and melanoma was enhanced in tumors enriched in clonal neoantigen [53].